Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Clinical Lung Cancer
|
December 3, 2014
Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer
Raymond H Mak, Gretchen Hermann, John H Lewis, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Automated Segmentation of Trunk Musculature with a Deep CNN Trained from Sparse Annotations in Radiation Therapy Patients with Metastatic Spine Disease
Vy Hong, Steve Pieper, Joanna James, et al.
Advances in Radiation Oncology
|
June 23, 2025
Spinal Instability Neoplastic Score as a Predictor of Vertebral Fracture in Patients Undergoing Radiation Therapy for Spinal Metastases: A Single-Institution Study
Patrick Doyle, Sarah Caplan, Neil Klinger, et al.
JAMA Oncology
|
August 1, 2024
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial
Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2015
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
David Kozono, Jie Li, Masayuki Nitta, et al.
JAMA Oncology
|
July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial
Helen J Ross, David Kozono, Xiaofei F Wang, et al.
JAMA Oncology
|
March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)
Kenneth L Kehl, David Zahrieh, Ping Yang, et al.
Immunotherapy
|
April 21, 2021
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)
Jacob M Sands, Sumithra J Mandrekar, David Kozono, et al.
The New England Journal of Medicine
|
February 13, 2023
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer
Nasser Altorki, Xiaofei Wang, David Kozono, et al.
Cancer Research
|
May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
Sharmistha Pal, David Kozono, Xiaodong Yang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Clinical Lung Cancer
|
December 3, 2014
Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer
Raymond H Mak, Gretchen Hermann, John H Lewis, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 20, 2025
Automated Segmentation of Trunk Musculature with a Deep CNN Trained from Sparse Annotations in Radiation Therapy Patients with Metastatic Spine Disease
Vy Hong, Steve Pieper, Joanna James, et al.
Advances in Radiation Oncology
|
June 23, 2025
Spinal Instability Neoplastic Score as a Predictor of Vertebral Fracture in Patients Undergoing Radiation Therapy for Spinal Metastases: A Single-Institution Study
Patrick Doyle, Sarah Caplan, Neil Klinger, et al.
JAMA Oncology
|
August 1, 2024
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial
Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2015
Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression
David Kozono, Jie Li, Masayuki Nitta, et al.
JAMA Oncology
|
July 25, 2024
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial
Helen J Ross, David Kozono, Xiaofei F Wang, et al.
JAMA Oncology
|
March 17, 2022
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)
Kenneth L Kehl, David Zahrieh, Ping Yang, et al.
Immunotherapy
|
April 21, 2021
Integration of immunotherapy into adjuvant therapy for resected non-small-cell lung cancer: ALCHEMIST chemo-IO (ACCIO)
Jacob M Sands, Sumithra J Mandrekar, David Kozono, et al.
The New England Journal of Medicine
|
February 13, 2023
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer
Nasser Altorki, Xiaofei Wang, David Kozono, et al.
Cancer Research
|
May 16, 2018
Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas
Sharmistha Pal, David Kozono, Xiaodong Yang, et al.
Page
of 8